Tata Chemicals, INE092A01019

Tata Chemicals launched safety center: what it means for Tata Chemicals stock

Published on 10/14/2026 at 01:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Tata Chemicals launched Suraksha Gurukul on September 28, 2026. For Tata Chemicals stock, revenue reached INR 42.55 billion.

Operating milestones and margins

  • Tata Chemicals acquired customer contracts worth over USD 110.00 million on August 29, 2026.
  • Consolidated revenue reached INR 42.55 billion and EBITDA margin was 13.00 percent in the first quarter of fiscal 2027.
  • Motilal Oswal retained a Neutral rating and an INR 700.00 target on July 28, 2026.
Tata Chemicals, INE092A01019, Illustration mit AI erstellt.
Tata Chemicals, INE092A01019, Illustration mit AI erstellt.

Tata Chemicals (ISIN INE092A01019) launched the Suraksha Gurukul safety training center at Mithapur on September 28, 2026, according to Tata Chemicals. For Tata Chemicals stock, the more important financial signal is the split between resilient Indian operations and pressure across overseas soda ash markets.

Three dated operating milestones

On July 27, 2026, Tata Chemicals reported first-quarter fiscal 2027 consolidated revenue of INR 42.55 billion and consolidated EBITDA of INR 5.55 billion, according to Tata Chemicals. On August 29, 2026, its North American business acquired customer contracts expected to generate more than USD 110.00 million in revenue through 2028, the investor-relations page said. On September 28, 2026, the Mithapur business launched Suraksha Gurukul, adding a concrete safety initiative to the recent operating timeline.

What does the latest quarter show?

DSIJ reported on July 28, 2026, that consolidated revenue rose 14.00 percent year over year to INR 42.55 billion, while EBITDA declined 15.00 percent to INR 5.55 billion. The EBITDA margin contracted to 13.00 percent from the prior-year level, and adjusted net income was a loss of INR 170.00 million versus an estimated adjusted profit of INR 351.00 million.

The regional contrast is sharper. Indian standalone revenue increased 10.00 percent year over year to INR 12.81 billion, while standalone EBITDA rose 35.00 percent to INR 3.64 billion and the EBITDA margin expanded to 28.40 percent. That leaves the domestic business as the clearest quantified offset to international pricing and cost pressure.

Analyst target stays at INR 700

Motilal Oswal Financial Services retained a Neutral rating and an INR 700.00 sum-of-the-parts target in its July 28, 2026 report, according to DSIJ. The broker expects revenue and EBITDA compound annual growth rates of 10.00 percent and 27.00 percent, respectively, over fiscal 2026 to fiscal 2028, while citing Chinese oversupply and weak international soda ash economics as risks.

The operating split matters

Tata Chemicals enters the next reporting cycle with measurable expansion in India, a USD 110.00 million North American contract opportunity and a 13.00 percent consolidated EBITDA margin in the latest reported quarter. The combination points to an investor debate centered on whether domestic growth can offset weaker overseas profitability.

Tata Chemicals key facts

  • Company: Tata Chemicals Limited
  • ISIN: INE092A01019
  • Ticker: TATACHEM
  • Sector / Industry: Materials / Chemicals

Market context: Market report BSE Sensex.

More news and analyses on Tata Chemicals stock

Disclaimer...

en | INE092A01019 | TATA CHEMICALS | boerse | 70318153 | bgmi